**Core Concept:** Opioid dependence is a condition resulting from chronic opioid exposure, characterized by withdrawal symptoms, tolerance, and compulsive drug-seeking behavior. Maintenance therapy aims to reduce these symptoms and prevent relapse by providing a stable opioid dose to the patient.

**Why the Correct Answer is Right:** Methadone is a synthetic opioid with a different mechanism of action from morphine, heroin, and other natural opioids. It is used as a part of a structured treatment program to reduce withdrawal symptoms, cravings, and prevent relapse in opioid-dependent patients. Methadone's long half-life ensures a stable plasma concentration throughout the day, allowing patients to function normally during treatment.

**Why Each Wrong Option is Incorrect:**
A. Suboxone (buprenorphine) is a partial opioid agonist with a lower risk of respiratory depression and addiction compared to methadone. However, it is not suitable for all patients, as it is not effective in treating opioid-induced constipation and is contraindicated in patients with severe respiratory depression or history of opioid-induced respiratory depression.

B. Naltrexone is an opioid antagonist, blocking the effects of opioids at the receptor level. However, it does not address the psychological dependence and cravings in opioid-dependent patients.

C. Buprenorphine is a partial opioid agonist with fewer respiratory effects than methadone but similar to Suboxone. It addresses opioid-induced constipation, unlike Suboxone, but is contraindicated in patients with severe respiratory depression or history of opioid-induced respiratory depression.

D. Peptides like naltrexone, buprenorphine, and methadone are used for maintenance therapy in opioid dependence, while Suboxone (buprenorphine) also addresses opioid-induced constipation.

**Clinical Pearl:** A comprehensive treatment plan for opioid dependence should consider the patient's individual needs, medical history, and contraindications. While methadone is a common choice due to its long half-life, these options provide alternative approaches for different patient profiles. For instance, buprenorphine may be preferred in patients experiencing constipation, and naltrexone is contraindicated in patients with a history of severe respiratory depression or who are taking other medications that interact negatively with it.

**Correct Answer: Suboxone (buprenorphine)**

Suboxone, a combination of buprenorphine and naloxone, is used as a maintenance therapy for opioid dependence. Buprenorphine is a partial opioid agonist that reduces withdrawal symptoms, cravings, and prevents relapse in patients who have failed to respond to other treatments, such as naltrexone. Naloxone, an opioid antagonist, is included to prevent abuse via injection, as it reverses the effects of other opioids, preventing misuse of Suboxone itself.

In comparison to methadone, Suboxone has fewer respiratory side effects due to its partial agonist activity, making it a suitable choice for patients with a history of severe respiratory depression or taking medications that interact negatively with methadone